Results 261 to 270 of about 15,172 (358)

Regulatory T cell therapy for xenotransplantation, what perspectives? [PDF]

open access: yesFront Immunol
Porret R   +10 more
europepmc   +1 more source

From simplification to sophistication: Secondary students' conceptual change in understanding machine learning model decision making

open access: yesBritish Journal of Educational Technology, EarlyView.
Abstract As artificial intelligence (AI) reshapes the educational landscape, promoting AI literacy in secondary education has become increasingly important. Understanding how secondary students perceive AI, particularly the machine learning (ML) decision‐making process, is critical for equipping them to navigate an AI‐driven future.
Liu Dong   +4 more
wiley   +1 more source

Anticipating data sharing for student‐centred education: Governmental policy initiatives in Switzerland and Japan

open access: yesBritish Journal of Educational Technology, EarlyView.
In the context of digital transformation and platformisation of education, policy concerns are shifting from infrastructure to data use. New governmental initiatives attempt to facilitate data sharing between schools, research and governing authorities to improve student learning. These attempts to create public data spaces anticipate new topologies of
Judith Hangartner   +2 more
wiley   +1 more source

Tau‐targeting active immunotherapy slows progression and reduces pathology in mouse models of tauopathy

open access: yesBrain Pathology, EarlyView.
The efficacy of the novel anti‐tau active immunotherapy, p5555kb, was tested using two mouse models of tau pathology. p5555kb inoculation increased the survival rate and reduced tau pathology in tau‐overexpressing P301L mice and decreased tau seeding in the brains of C57BL/6 mice injected with human‐purified Alzheimer's disease tau.
Christopher M. Brown   +7 more
wiley   +1 more source

The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley   +1 more source

Home - About - Disclaimer - Privacy